Protego Biopharma

About Protego Biopharma

Protego Biopharma is a biotech company focused on discovering and developing first-in-class small molecule therapeutics that reprogram protein folding to treat protein misfolding diseases. The company targets monogenic protein misfolding disorders affecting muscles, heart, kidneys, retina, and other organs, leveraging pharmacological chaperones to stabilize target proteins and restore healthy structure and function. Their approach also involves modulating cellular stress pathways to enhance proteostasis and employs data-driven target selection and translational research to enable biomarker-driven clinical readouts. Based in San Diego, California, Protego Biopharma pursues disease-modifying therapies with a translational research pipeline and strategic leadership in the biopharma sector.